CD1D and autoimmune disease: Here, we have engineered αGalCer/CD1d-NPs to investigate if the (potentially plastic) liver-resident αGalCer/CD1d-binding iNKT cells can be re-programmed into liver-autoimmune disease-suppressing cells.